Department of Obstetrics-Gynecology and Human Reproduction, CHU Clermont-Ferrand, CHU Estaing, Universite d' Auvergne, Clermont-Ferrand, France.
J Minim Invasive Gynecol. 2011 Sep-Oct;18(5):589-96. doi: 10.1016/j.jmig.2011.05.015. Epub 2011 Jun 29.
To assess the surgical outcomes and long-term results of laparoscopic treatment of endometrial cancer in obese patients, and compare these results with those of nonobese women.
Retrospective cohort study (Canadian Task Force classification II-2).
Two referral cancer centers.
Fifty-two obese and 155 nonobese women with clinical stage I endometrial cancer managed by laparoscopy from 1990-2005 in two referral centers.
Demographic, surgical, perioperative and pathological characteristics of obese women and nonobese women with endometrial cancer treated by laparoscopy were analyzed and then compared. Recurrence-free and overall survival was calculated by use of Kaplan-Meier method.
Median BMI of the study population was 26.2 Kg/m(2). Median BMI among obese patients was 34.2 Kg/m(2). The conversion rate was independent from the BMI of the patient (3.8% vs 4.5%, p = .80). Neither mean operative time (187.5 vs 172 min, p = .11) neither hospital stay (5.2 vs 4.9 days, p = .44) were related with BMI. Lymphadenectomy was considered not feasible in 7 obese (17%) and 8 nonobese (7%) women (p = 0.09). Fewer lymph nodes were retrieved among obese women (8 versus 11, p <.0002). No differences were found between the groups in terms of perioperative complications. Median follow-up was 69 and 71 months for the obese and nonobese, respectively (p = .59). Overall and disease-free 5-year survival rates did not differ between obese and nonobese patients (90.3% and 87.5% versus 88.5% and 89.8%, respectively).
Despite some limitations, the laparoscopic approach seems to be particularly useful for obese patients with endometrial cancer, with similar survival and recurrence rates and without any more complications compared to the nonobese population.
评估肥胖患者腹腔镜治疗子宫内膜癌的手术结果和长期疗效,并将这些结果与非肥胖女性进行比较。
回顾性队列研究(加拿大任务组分类 II-2)。
两家转诊癌症中心。
1990 年至 2005 年间在两家转诊中心接受腹腔镜治疗的 52 名肥胖和 155 名非肥胖临床 I 期子宫内膜癌患者。
分析并比较肥胖和非肥胖子宫内膜癌患者的人口统计学、手术、围手术期和病理特征。采用 Kaplan-Meier 法计算无复发生存率和总生存率。
研究人群的中位 BMI 为 26.2kg/m²。肥胖患者的中位 BMI 为 34.2kg/m²。转换率与患者的 BMI 无关(3.8%比 4.5%,p=0.80)。手术时间(187.5 分钟比 172 分钟,p=0.11)和住院时间(5.2 天比 4.9 天,p=0.44)均与 BMI 无关。7 名肥胖患者(17%)和 8 名非肥胖患者(7%)认为淋巴结清扫术不可行(p=0.09)。肥胖女性的淋巴结检出数较少(8 枚比 11 枚,p<0.0002)。两组患者的围手术期并发症无差异。肥胖和非肥胖患者的中位随访时间分别为 69 个月和 71 个月(p=0.59)。肥胖和非肥胖患者的 5 年总生存率和无病生存率无差异(分别为 90.3%和 87.5%比 88.5%和 89.8%)。
尽管存在一些局限性,但腹腔镜方法对于肥胖子宫内膜癌患者似乎特别有用,与非肥胖人群相比,其生存率和复发率相似,且并发症无增加。